CONCLUSION
In summary, our study suggests that longitudinal changes in maternal
sFlt-1 levels from admission for confirmed PE add to baseline
characteristics in predicting maternal complications and interval to
delivery. Further studies are needed to evaluate the evolution of
angiogenic factors levels at fixed time points after admission and to
address the impact of incorporating this parameter in the clinical
management of early-onset PE on maternal and fetal outcomes.